ReviewGels (Basel, Switzerland)2026
Recent Advances in Diversified Materials for Spinal Cord Injury Repair and Regeneration.
Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Spinal cord injury (SCI) is a devastating central nervous system disorder that causes irreversible loss of sensory and motor functions below the lesion, seriously compromising patients' daily activities and quality of life. Due to the inherent shortcomings of existing therapeutic strategies and the rapid progress of material engineering, developing advanced functional materials has emerged as a promising approach for SCI treatment. This review comprehensively summarizes the applications of polymeric materials, inorganic materials, bioactive materials, and composite biomaterials for SCI treatment and regeneration, with a focus on their underlying mechanisms, therapeutic performance, and research trends. Cumulative evidence indicates that these materials possess versatile biological functions and great application potential in facilitating nerve regeneration and tissue reconstruction after SCI. In short, in-depth understanding of material-based therapeutic systems can offer innovative references for the optimization of SCI treatment regimens. Nevertheless, more preclinical and translational investigations are still indispensable to accelerate their clinical transformation and widespread practical use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.